Combinational Therapy of ABT-263 and GDC-0941 Exerts Synergistic Activity in Glioblastoma

被引:0
|
作者
Pareja, F. [1 ]
Greene, L. [1 ]
Siegelin, M. [1 ]
机构
[1] Columbia Univ, New York Presbyterian Hosp, New York, NY USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1808
引用
收藏
页码:441A / 441A
页数:1
相关论文
共 50 条
  • [1] Combinational Therapy of ABT-263 and GDC-0941 Exerts Synergistic Activity in Glioblastoma
    Pareja, F.
    Greene, L.
    Siegelin, M.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 441A - 441A
  • [2] Combination treatments of SCLC with ABT-263 and Immunotoxins produces synergistic killing of ABT-263-resistant cells
    Mattoo, Abid R.
    Fitzgerald, David J.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [3] Single Agent and Synergistic Activity of Maritoclax with ABT-263 in Nasopharyngeal Carcinoma (NPC) Cell Lines
    Xiang, Benedict Lian Shi
    Kwok-Wai, Lo
    Soo-Beng, Alan Khoo
    Mohana-Kumaran, Nethia
    [J]. TROPICAL LIFE SCIENCES RESEARCH, 2020, 31 (03) : 1 - 13
  • [4] Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263
    Shao, Huanjie
    Jing, Kai
    Mahmoud, Esraa
    Huang, Haihong
    Fang, Xianjun
    Yu, Chunrong
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (12) : 2640 - 2650
  • [5] GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1
    Zheng, Lin
    Yang, Wei
    Zhang, Chong
    Ding, Wan-jing
    Zhu, Hong
    Lin, Neng-ming
    Wu, Hong-hai
    He, Qiao-jun
    Yang, Bo
    [J]. CANCER LETTERS, 2011, 309 (01) : 27 - 36
  • [6] Synergistic Effects of TW-37 and ABT-263 on Renal Cell Carcinoma Cells
    Yu, Rui
    Lu, Yefen
    Yu, Ren
    Xie, Jianjun
    Zhou, Shoujun
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 953 - 963
  • [7] Combination treatments with ABT-263 and an immunotoxin produce synergistic killing of ABT-263-resistant small cell lung cancer cell lines
    Mattoo, Abid R.
    Fitzgerald, David J.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (04) : 978 - 987
  • [8] GDC-0941 and ABT-737 cooperate to sensitize isolated mitochondria from PI3K mutant cells
    Buron, N.
    Porceddu, M.
    Disley, D.
    Torrance, C.
    Borgne-Sanchez, A.
    [J]. EJC SUPPLEMENTS, 2010, 8 (07): : 47 - 47
  • [9] GDC-0941 PI3K inhibitor activity in preclinical lung cancer models
    Friedman, L.
    Belvin, M.
    Berry, L.
    Haverty, P.
    Hoeflich, K.
    Lackner, M.
    Sampath, D.
    Wallin, J.
    Yauch, B.
    [J]. EJC SUPPLEMENTS, 2010, 8 (07): : 51 - 51
  • [10] GDC-0941 enhances the lysosomal compartment via TFEB and primes glioblastoma cells to lysosomal membrane permeabilization and cell death
    Enzenmueller, Stefanie
    Gonzalez, Patrick
    Karpel-Massler, Georg
    Debatin, Klaus-Michael
    Fulda, Simone
    [J]. CANCER LETTERS, 2013, 329 (01) : 27 - 36